发明申请
US20080096920A1 Histone Deacetylase Inhibitors 有权
组蛋白脱乙酰酶抑制剂

Histone Deacetylase Inhibitors
摘要:
This invention relates to iminodiacetic acid and diamine hydroxamic acid derivatives, that are inhibitors of histone deacetylase (HDAC), and are useful in the prevention and/or treatment of cellular proliferative diseases, for example cancer, autoimmune, allergic and inflammatory diseases, diseases of the central nervous system (CNS) such as neurodegenerative diseases, and in the prevention and/or treatment of restenosis.
公开/授权文献
信息查询
0/0